首页> 外文期刊>Arthritis & rheumatology. >CD147/Basigin Limits Lupus Nephritis and Th17 Cell Differentiation in Mice by Inhibiting the Interleukin-6/STAT-3 Pathway
【24h】

CD147/Basigin Limits Lupus Nephritis and Th17 Cell Differentiation in Mice by Inhibiting the Interleukin-6/STAT-3 Pathway

机译:CD147 / Basigin通过抑制白介素-6 / STAT-3途径限制小鼠的狼疮性肾炎和Th17细胞分化

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. Interleukin-17 (IL-17)-producing T cells (Th17 cells) play critical roles in the pathogenesis of immune-related diseases, including systemic lupus erythematosus. However, the fundamental mechanism regulating Th17 cell differentiation is not fully understood. Recently, we demonstrated that plasma levels of CD147/basigin (Bsg) in patients with lupus nephritis (LN) were closely associated with disease activity. but the molecular mechanism involving Bsg has been elusive. Here, we addressed the role of Bsg in the pathogenesis of LN.
机译:目的。产生白介素17(IL-17)的T细胞(Th17细胞)在免疫相关疾病(包括系统性红斑狼疮)的发病机理中起关键作用。但是,调节Th17细胞分化的基本机制尚未完全了解。最近,我们证明狼疮性肾炎(LN)患者的血浆CD147 / basigin(Bsg)水平与疾病活动密切相关。但是涉及Bsg的分子机制尚不清楚。在这里,我们解决了Bsg在LN发病机理中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号